The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China

Thromb Res. 2023 Mar:223:123-126. doi: 10.1016/j.thromres.2023.01.025. Epub 2023 Feb 2.
No abstract available

Keywords: Immune tolerance induction; Relapse; Rescue regimen; Rituximab; Severe hemophilia A.

Publication types

  • Letter

MeSH terms

  • Child
  • China
  • Factor VIII
  • Hemophilia A*
  • Humans
  • Immune Tolerance
  • Rituximab

Substances

  • Rituximab
  • Factor VIII